SGRY - サ―ジェリ―・パ―トナ―ズ （Surgery Partners Inc.）

We provide readers with equity investment subjects that probably may experience rising market prices in next 3-5 months. We examine Surgery Partners here. Click here to read.

BRENTWOOD, Tenn., June 29, 2022 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its second quarter 2022 results before the market opens on Tuesday, August 2, 2022, to be followed by a conference call at 8:30 a.m. (Eastern Time)

Surgery Partners Inc (SGRY) shares closed this week 20.9% lower than it did at the end of last week. The stock is currently down 47.2% year-to-date, down 56.1% over the past 12 months, and up 25.1% over the past five years. This week, the Dow Jones Industrial Average fell 4.8%, and the S&P 500 fell 5.7%. Trading Activity Shares traded as high as $32.43 and as low as $26.66 this week.Shares closed 59.2% below its 52-week high and 6.6% above its 52-week low.Trading volume this week was 10.4% lower than the 10-day average and 13.2% higher than the 30-day average.Beta, a measure of the stock’s volatility relative to the overall market stands at 1.9. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold.The stock closed at 3.5% lower than its 5-day moving average, 22.0% lower than its 20-day moving average, and 41.2% lower than its 90-day moving average. Market Comparative Performance The company's share price lags the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price lags the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis The company share price lags the performance of its peers in the Health Care industry sector this week, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 531.6% The company's stock price performance over the past 12 months lags the peer average by 469.3% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

In the last trading session, 1.14 million Surgery Partners Inc. (NASDAQ:SGRY) shares changed hands as the company’s beta touched 2.79. With the company’s per share price at $30.82 changed hands at -$0.11 or -0.36% during last session, the market valuation stood at $2.96B. SGRY’s last price was a discount, traded about -125.76% off its 52-week … Surgery Partners Inc. (NASDAQ: SGRY): The Most Interesting Shares Today Read More »

Today’s update reveals the Most Bought and Sold Securities from retail investors over the last seven days. Below you will find the total share of the fund flows dedicated to each security. Top 5 Purchased Securities This Week: Surgery Partners Inc (NASDAQ:SGRY) Last week, retail investors on Fintel bought the 16.5% dip in SRGY shares. The […]

Surgery Partners, Inc. (NASDAQ:NASDAQ:SGRY) Q1 2022 Earnings Conference Call May 03, 2022 08:30 AM ET Company Participants Dave Doherty - Chief Financial Officer Wayne DeVeydt - Executive…

SGRY earnings call for the period ending March 31, 2022.

Surgery Partners (SGRY) announced a strategic partnership with value-based care services provider ValueHealth.

UNITED STATES, May 3, 2022 /⁨EINPresswire.com⁩/ -- Surgery Partners, Inc. (NASDAQ: SGRY) (Surgery Partners) and ValueHealth, LLC (ValueHealth) today announced a strategic partnership that brings Surgery Partners, a leading independent operator of …

Surgery Partners press release (SGRY): Q1 GAAP EPS of $0.14 beats by $0.30.Revenue of $596.2M (+16.4% Y/Y) beats by $26.38M.

Surgery Partners (NASDAQ:SGRY) released its earnings results on Tuesday. The company reported ($0.05) EPS for the quarter, beating analysts consensus estimates of ($0.09) by $0.04, MarketWatch Earnings reports. Surgery Partners had a negative return on equity of 1.93% and a negative net margin of 4.95%. During the same period in the prior year, the company []

Occudo Quantitative Strategies LP purchased a new stake in Surgery Partners, Inc. (NASDAQ:SGRY) during the second quarter, according to its most recent filing with the SEC. The fund purchased 3,902 shares of the companys stock, valued at approximately $260,000. A number of other hedge funds and other institutional investors also recently made changes to their []

Equities research analysts at JPMorgan Chase & Co. initiated coverage on shares of Surgery Partners (NASDAQ:SGRY) in a research note issued on Monday, Analyst Price Targets reports. The brokerage set a neutral rating and a $50.00 price target on the stock. JPMorgan Chase & Co.s price objective would indicate a potential upside of 21.80% from []

Bain Capital Investors LLC lifted its stake in Surgery Partners, Inc. (NASDAQ:SGRY) by 85.5% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 49,064,576 shares of the company’s stock after buying an additional 22,608,925 shares during the quarter. Surgery Partners makes up 31.9% of Bain […]